InsiderTrades

Form 4 for GILD Gilead Sciences

Accepted 2024-12-16 00:00:00 ET · period of report 2023-12-13 · accession 0001127602-24-029490 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DM 2024-12-16 2023-12-13+ GILD Patterson Sandra SVP, Controllership M - OptEx — +455 37.5K +1% —
DM 2024-12-16 2023-12-13+ GILD Patterson Sandra SVP, Controllership F - Tax $86.12 -455 37.1K -1% -$39.2K
DM 2024-12-16 2023-12-13+ GILD Patterson Sandra SVP, Controllership M - OptEx — -455 12.0K -4% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2023-12-13 M A 117 — 37,376 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
2 Common Common Stock 2023-12-13 F D 298 $83.09 37,235 D — —
3 Common Common Stock 2024-12-13 F D 157 $91.86 37,078 D — —
4 Common Common Stock 2023-12-13 M A 181 — 37,259 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
5 Common Common Stock 2024-12-13 M A 157 — 37,533 D — — (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock.
6 Derivative Restricted Stock Unit 2024-12-13 M D 157 — 11,827 D — · — to — 157 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F4) The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.
7 Derivative Restricted Stock Unit 2023-12-13 M D 181 — 12,101 D — · — to — 181 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F3) The restricted stock units have a three year vesting schedule. 33.33% vest on each yearly anniversary of the date of grant until fully vested.
8 Derivative Restricted Stock Unit 2023-12-13 M D 117 — 11,984 D — · — to — 117 Common Stock (F1) Each restricted stock unit represents the contingent right to receive one share of Gilead Sciences, Inc.'s common stock. (F4) The restricted stock units have a four year vesting schedule. 25% vest on the first anniversary of the date of grant. The balance will vest 6.25% quarterly thereafter until fully vested.